Thank you for posting this Matt. Jim
"The process, advanced by Cannabics Pharmaceuticals, expands the firm’s proprietary know-how of personalization of CBD drug. The prevailing invention relates to a combined system and method for evaluating the sensitivity of a numerous of CBD-based treatment modalities on patient-based primary tumor biopsies and blood circulating tumor cells. This recent patent submission is a strong message and a dynamic reflection of the firm’s target: Cannabics products and methods will allow exquisitely accurate medical cannabis offerings to be applied into mainstream medical practice in the coming period".